Chiara Dellepiane

Evaluation of COVID-19 impact on DELAYing diagnostic-therapeutic pathways of lung cancer patients in Italy (COVID-DELAY study): fewer cases and higher stages from a real-world scenario

Luca Cantini, Giulia Mentrasti, Gian Luigi Russo et al. · ESMO Open · 2022 · 65 citations · Full text

Medicine, Oncology, Cancer Epidemiology +16

T-DM1 Efficacy in Patients With HER2-positive Metastatic Breast Cancer Progressing After a Taxane Plus Pertuzumab and Trastuzumab: An Italian Multicenter Observational Study

Benedetta Conte, Alessandra Fabi, Francesca Poggio et al. · Clinical Breast Cancer · 2019 · 52 citations

Medicine, Oncology, Pharmacotherapy +17

Prospective study to optimize care and improve knowledge on ovarian function and/or fertility preservation in young breast cancer patients: Results of the pilot phase of the PREgnancy and FERtility (PREFER) study

Matteo Lambertini, Valeria Fontana, Claudia Massarotti et al. · The Breast · 2018 · 48 citations

Medicine, Gynecology, Oncology +17

Impact of body mass index on the clinical outcomes of patients with HER2-positive metastatic breast cancer

Samuel Martel, Elena Poletto, Arlindo R. Ferreira et al. · The Breast · 2017 · 44 citations · Full text

Medicine, Cancer Biology, Oncology +16

Prognostic Role of Soluble and Extracellular Vesicle-Associated PD-L1, B7-H3 and B7-H4 in Non-Small Cell Lung Cancer Patients Treated with Immune Checkpoint Inhibitors

Carlo Genova, Roberta Tasso, Alessandra Rosa et al. · Cells · 2023 · 34 citations · Full text

Life Sciences, Immunology, Oncology +17